206 related articles for article (PubMed ID: 8695042)
21. Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents.
Millan MJ; Gobert A; Bervoets K; Rivet JM; Veiga S; Brocco M
J Pharmacol Exp Ther; 2000 Feb; 292(2):672-83. PubMed ID: 10640305
[TBL] [Abstract][Full Text] [Related]
22. The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.
Hauber W; Waldenmeier MT
Eur J Pharmacol; 1994 May; 256(3):339-42. PubMed ID: 7913894
[TBL] [Abstract][Full Text] [Related]
23. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
De Leonibus E; Mele A; Oliverio A; Pert A
Neuroscience; 2001; 104(1):105-16. PubMed ID: 11311535
[TBL] [Abstract][Full Text] [Related]
24. Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17.
Léna I; Chessel A; Le Pen G; Krebs MO; Garcia R
Psychopharmacology (Berl); 2007 Jun; 192(3):373-83. PubMed ID: 17279373
[TBL] [Abstract][Full Text] [Related]
25. Effect of glutamate receptor antagonists on suckling-induced prolactin release in rats.
Zelena D; Makara GB; Nagy GM
Endocrine; 2003 Jul; 21(2):147-52. PubMed ID: 12897378
[TBL] [Abstract][Full Text] [Related]
26. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors.
Feenstra MG; Botterblom MH; van Uum JF
J Neurochem; 1998 Mar; 70(3):1104-13. PubMed ID: 9489731
[TBL] [Abstract][Full Text] [Related]
27. Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain.
D'Souza DN; Harlan RE; Garcia MM
Neuroscience; 1999; 93(4):1539-47. PubMed ID: 10501478
[TBL] [Abstract][Full Text] [Related]
28. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M
Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650
[TBL] [Abstract][Full Text] [Related]
29. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.
Kosowski AR; Cebers G; Cebere A; Swanhagen AC; Liljequist S
Psychopharmacology (Berl); 2004 Aug; 175(1):114-23. PubMed ID: 15088078
[TBL] [Abstract][Full Text] [Related]
30. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.
Mele A; Thomas DN; Pert A
Neuroscience; 1998 Jan; 82(1):43-58. PubMed ID: 9483502
[TBL] [Abstract][Full Text] [Related]
31. Behavioural pharmacology of the non-competitive NMDA antagonists dextrorphan and ADCI: relations between locomotor stimulation, anticataleptic potential and forebrain dopamine metabolism.
Bubser M; Zadow B; Kronthaler UO; Felsheim U; Rückert NG; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):767-73. PubMed ID: 9205962
[TBL] [Abstract][Full Text] [Related]
32. NMDA receptor antagonist-induced dopamine release in the ventral pallidum does not correlate with motor activation.
Kretschmer BD
Brain Res; 2000 Mar; 859(1):147-56. PubMed ID: 10720624
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release.
Zelena D; Makara GB; Jezova D
Neuroendocrinology; 1999 May; 69(5):316-23. PubMed ID: 10343172
[TBL] [Abstract][Full Text] [Related]
34. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.
Shoaib M; Benwell ME; Akbar MT; Stolerman IP; Balfour DJ
Br J Pharmacol; 1994 Apr; 111(4):1073-80. PubMed ID: 8032593
[TBL] [Abstract][Full Text] [Related]
35. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
36. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine.
De La Garza R; Jentsch JD; Verrico CD; Roth RH
Brain Res; 2002 Dec; 958(1):20-7. PubMed ID: 12468026
[TBL] [Abstract][Full Text] [Related]
37. Excitatory amino acid antagonists attenuate the effects of cocaine on extracellular dopamine in the nucleus accumbens.
Pap A; Bradberry CW
J Pharmacol Exp Ther; 1995 Jul; 274(1):127-33. PubMed ID: 7616389
[TBL] [Abstract][Full Text] [Related]
38. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
[TBL] [Abstract][Full Text] [Related]
39. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
Abekawa T; Ito K; Nakagawa S; Koyama T
Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
[TBL] [Abstract][Full Text] [Related]
40. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
